The U.S. Food and Drug Administration approved Opill in July. The over-the-counter daily birth control pill is now hitting shelves nationwide. CVS also said they will offer Opill once they receive their shipments.
Opill will hit shelves at Walgreens locations across the nation starting this week, the company said.
A spokesperson confirmed it will be on shelves “nationwide,” which encompasses more than 8,700 stores. It will be stocked in the family planning aisle and at their pharmacies. It will also be available online for pickup and delivery.
While the first shipments arrived at Walgreens distribution centers Monday and began shipping out to brick-and-mortar stores, it will take until early April for all stores to have the product.
Walgreens will price Opill at $19.99 for a one month pack and $49.99 for a three month pack, in line with other retailers like Amazon and Opill.com are charging.
“Because privacy is important to Perrigo, Opill orders will be sent in plain, unbranded boxes,” wrote Sara Young, senior vice president and chief consumer officer at Perrigo.
“Opill will be available at CVS.com and through the CVS Pharmacy app in late March,” spokesperson Matt Blanchette wrote in an email. “In early April more than 7,500 CVS Pharmacy stores will offer Opill and for added privacy and convenience, customers will be able to choose same-day delivery or buy online and pick-up in store.”
Those Who Will Benefit the Most
There is no age limit for the use of Opill, so it will benefit teenagers who may have been reluctant to let their parents know they may be sexually active.
In addition, the pill will help those who may not have health insurance and cannot afford the costs of a doctor’s visit that has been a requirement of receiving birth control in the past.
Online access to Opill will also benefit women who live in remote rural areas or who may not have access to transportation in order to travel to stores that carry it, said Dr. Anne-Marie Amies Oelschlager, professor of obstetrics and gynecology at the University of Washington School of Medicine, who specializes in adolescent care.
“The biggest population that will benefit from this are those who have limited access to contraception in the first place. There are a lot of people in our country that live in what we would call contraceptive deserts, and these are areas where they have limited to no access to a reproductive health care provider, meaning they’d have to drive really far away to be able to access a provider, or they may not have access to a pharmacy close by,” Oelschlager said.
Opill will also be available online. At Opill.com, a six-month supply will be available for $89.99.
State-by-State Restrictions Possible
Last year, when the US Food and Drug Administration approved Opill for use without a prescription and with no age limit, public health experts applauded the move as a milestone for the expansion of access to contraception in the United States. Now that the rollout has begun, however, there is some concern that states could place restrictions on that access.
“We live in a time when everything having to do with people’s sexual and reproductive health, and people’s ability to realize their reproductive goals and pursue reproductive freedoms, is unfortunately politicized,” Megan Kavanaugh, a principal research scientist at the Guttmacher Institute, a nonprofit that has been tracking the rollout of Opill.
No states have made such proposals or actions on restricting access to Opill, but the concern stems from the US Supreme Court’s Dobbs decision in 2022, which reversed Roe v. Wade and overturned the constitutional right to an abortion.
Some states may try to enforce age restrictions on Opill, Dr. Vineeta Gupta, executive director for the nonprofit the Network for Public Health Law, said in an email.
There are age restrictions on certain medications on a state-by-state basis in other contexts, such as with over-the-counter drugs containing the cough suppressant dextromethorphan, said Gupta, who wrote a blog post about this topic.
In 2012, California became the first state to prohibit the sale of cough medicines containing dextromethorphan to minors, and since then, governors from several other states have signed similar laws.
Separately, when it comes to Plan B emergency contraception, there have been some attempts to enforce state-by-state differences in age restrictions, too.
Plan B was approved for over-the-counter use for adults in 2006, and in 2013, it was approved for all ages. That year, “Oklahoma passed a law requiring anyone 17 and under to obtain a prescription before Plan B could be dispensed to them. The state was sued and the plaintiffs, represented by the Center for Reproductive Rights, prevailed. The law was held to be unconstitutional because it violated the state’s single subject rule,” Gupta said in the email. That rule prohibits individual pieces of legislation or ballot initiatives from addressing more than one issue or unrelated issues in a single law.
But these examples have not set a precedent for what type of authority states may have to restrict access to an FDA-approved medication, Gupta said.
When it comes to Opill, “many states also allow pharmacists to refuse to participate in ‘health care’ that they find morally objectionable. This could include providing individuals with Opill even though it is OTC,” she said. “Legal approval and actual access are two distinct issues, with the latter influenced by a broader set of factors including state policies, healthcare practices, and socio-economic determinants of health.”